Literature DB >> 1975267

(+)-PHNO: a new anti-parkinsonian agent which does not induce chorea in MPTP-treated squirrel monkeys.

N M Rupniak, S Boyce, M J Steventon, S D Iversen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975267      PMCID: PMC488146          DOI: 10.1136/jnnp.53.7.622

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  12 in total

1.  Behavioural effects of (+)-4-propyl-9-hydroxynaphthoxazine in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  C E Clarke; S Boyce; M A Sambrook; S M Stahl; A R Crossman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

2.  Injected apomorphine and orally administered levodopa in Parkinsonism.

Authors:  S E Düby; G C Cotzias; P S Papavasiliou; W H Lawrence
Journal:  Arch Neurol       Date:  1972-12

3.  Blockade by apomorphine of haloperidol-induced dyskinesia in schizophrenic patients.

Authors:  R Gessa; A Tagliamonte; G L Gessa
Journal:  Lancet       Date:  1972-11-04       Impact factor: 79.321

4.  The choreoathetoid movement disorder induced by levodopa.

Authors:  C H Markham
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

Review 5.  Recent advances in drug delivery technology for neurology.

Authors:  S M Stahl; K M Wets
Journal:  Clin Neuropharmacol       Date:  1988-02       Impact factor: 1.592

6.  Autoradiographic localization of dopamine D1 binding sites in areas receiving striatal input.

Authors:  W C Graham; A R Crossman
Journal:  Eur J Pharmacol       Date:  1987-10-27       Impact factor: 4.432

7.  Dyskinesia in the primate following injection of an excitatory amino acid antagonist into the medial segment of the globus pallidus.

Authors:  R G Robertson; S M Farmery; M A Sambrook; A R Crossman
Journal:  Brain Res       Date:  1989-01-09       Impact factor: 3.252

8.  (+)-4-Propyl-9-hydroxynaphthoxazine (PHNO), a new dopaminomimetic, in treatment of parkinsonism.

Authors:  A J Stoessl; E Mak; D B Calne
Journal:  Lancet       Date:  1985-12-14       Impact factor: 79.321

9.  Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.

Authors:  G U Corsini; P Onali; C Masala; C Cianchetti; A Mangoni; G Gessa
Journal:  Arch Neurol       Date:  1978-01

10.  Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding.

Authors:  P J Bédard; T Di Paolo; P Falardeau; R Boucher
Journal:  Brain Res       Date:  1986-08-06       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.